Met Life Investment Management, LLC Mei Pharma, Inc. Transaction History

Met Life Investment Management, LLC

$16.6 Billion
Q2 2024

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.42 - $0.65 $33,585 - $51,977	-79,966 Closed	0 $0
Q1 2022 May 10, 2024	BUY	$0.54 - $2.74 $43,181 - $219,106	79,966 New	79,966 $47,000
Q1 2022 Jun 20, 2023	BUY	$0.54 - $2.74 $43,181 - $219,106	79,966 New	79,966 $47,000
Q1 2022 Mar 22, 2023	BUY	$0.54 - $2.74 $39,143 - $198,617	72,488 Added 969.35%	79,966 $47,000
Q1 2022 May 12, 2022	BUY	$0.54 - $2.74 $39,143 - $198,617	72,488 Added 969.35%	79,966 $48,000
Q4 2021 May 17, 2024	SELL	$2.33 - $3.37 $78,043 - $112,878	-33,495 Reduced 81.75%	7,478 $19,000
Q4 2021 Jun 21, 2023	BUY	$2.33 - $3.37 $17,423 - $25,200	7,478 New	7,478 $19,000
Q4 2021 Mar 22, 2023	SELL	$2.33 - $3.37 $78,043 - $112,878	-33,495 Reduced 81.75%	7,478 $19,000
Q4 2021 Feb 15, 2022	SELL	$2.33 - $3.37 $78,043 - $112,878	-33,495 Reduced 81.75%	7,478 $20,000
Q3 2021 May 17, 2024	BUY	$2.52 - $2.99 $74,297 - $88,154	29,483 Added 256.6%	40,973 $113,000
Q3 2021 Jun 21, 2023	BUY	$2.52 - $2.99 $103,251 - $122,509	40,973 New	40,973 $113,000
Q3 2021 Mar 22, 2023	BUY	$2.52 - $2.99 $74,297 - $88,154	29,483 Added 256.6%	40,973 $113,000
Q3 2021 Nov 15, 2021	BUY	$2.52 - $2.99 $74,297 - $88,154	29,483 Added 256.6%	40,973 $113,000
Q2 2021 May 17, 2024	SELL	$2.6 - $3.65 $94,731 - $132,987	-36,435 Reduced 76.03%	11,490 $32,000
Q2 2021 Jun 21, 2023	BUY	$2.6 - $3.65 $29,874 - $41,938	11,490 New	11,490 $32,000
Q2 2021 Mar 22, 2023	SELL	$2.6 - $3.65 $94,731 - $132,987	-36,435 Reduced 76.03%	11,490 $32,000
Q2 2021 Aug 16, 2021	SELL	$2.6 - $3.65 $94,731 - $132,987	-36,435 Reduced 76.03%	11,490 $33,000
Q1 2021 May 17, 2024	BUY	$2.73 - $4.5 $130,835 - $215,662	47,925 New	47,925 $164,000
Q1 2021 Jun 26, 2023	BUY	$2.73 - $4.5 $130,835 - $215,662	47,925 New	47,925 $164 Million
Q1 2021 Mar 22, 2023	BUY	$2.73 - $4.5 $98,157 - $161,797	35,955 Added 300.38%	47,925 $164,000
Q1 2021 May 14, 2021	BUY	$2.73 - $4.5 $98,157 - $161,797	35,955 Added 300.38%	47,925 $164,000
Q4 2020 May 24, 2024	SELL	$2.6 - $3.32 $26,517 - $33,860	-10,199 Reduced 46.01%	11,970 $31,000
Q4 2020 Jun 22, 2023	BUY	$2.6 - $3.32 $31,122 - $39,740	11,970 New	11,970 $31,000
Q4 2020 Mar 22, 2023	SELL	$2.6 - $3.32 $26,517 - $33,860	-10,199 Reduced 46.01%	11,970 $31,000
Q4 2020 Feb 16, 2021	SELL	$2.6 - $3.32 $26,517 - $33,860	-10,199 Reduced 46.01%	11,970 $32,000
Q3 2020 May 24, 2024	SELL	$2.46 - $4.27 $66,717 - $115,806	-27,121 Reduced 55.02%	22,169 $69.2 Million
Q3 2020 Jun 26, 2023	BUY	$2.46 - $4.27 $54,535 - $94,661	22,169 New	22,169 $69,000
Q3 2020 Mar 22, 2023	SELL	$2.46 - $4.27 $66,717 - $115,806	-27,121 Reduced 55.02%	22,169 $69,000
Q3 2020 Nov 13, 2020	SELL	$2.46 - $4.27 $66,717 - $115,806	-27,121 Reduced 55.02%	22,169 $69,000
Q2 2020 May 24, 2024	BUY	$1.45 - $4.3 $71,470 - $211,947	49,290 New	49,290 $204 Million
Q2 2020 Jun 26, 2023	BUY	$1.45 - $4.3 $71,470 - $211,947	49,290 New	49,290 $203,000
Q2 2020 Mar 22, 2023	BUY	$1.45 - $4.3 $71,470 - $211,947	49,290 New	49,290 $203,000
Q2 2020 Aug 14, 2020	BUY	$1.45 - $4.3 $71,470 - $211,947	49,290 New	49,290 $204,000

Others Institutions Holding MEIP

# of Institutions

Shares Held

Call Options Held

Put Options Held

Urban Wealth Management, LLC

2K
Shares

$5,497
0.0% of portfolio

View Full List

About MEI Pharma, Inc.

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $366M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

More about MEIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account